OnCall
A podcast from Cencora where we discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go. OnCall will make it easy for you to access the education you want - whenever you want.
Episodes
39 episodes
Biosimilar Basics: Payer Perspective
In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com...
•
22:41
Biosimilar Basics: Legislation
In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.O...
•
16:27
Biosimilar Basics: Market Landscape
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in ...
•
19:26
Biosimilar Basics: Overview
In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.
•
Episode 1
•
17:47
GPO Legislative Townhall December 2023: Part 11
In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.If you have any questions for our guests or have a topic you would like...
•
Episode 11
•
8:24
GPO Legislative Townhall December 2023: Part 10
In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.Our next episode will ...
•
Episode 10
•
15:32
GPO Legislative Townhall December 2023: Part 9
In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.Our next episode will feature inform...
•
Episode 9
•
12:30
GPO Legislative Townhall August 2023: Part 8
In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.That's all for this episode of On...
•
Episode 8
•
28:24
GPO Legislative Townhall August 2023: Part 7
In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.Our next episode will feature information on issues regarding MPFS...
•
Episode 7
•
16:30
GPO Legislative Townhall May 2023: Part 6
In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments.Our next episode will...
•
Episode 6
•
15:39
GPO Legislative Townhall May 2023: Part 5
In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices.Our next episode will feature...
•
Episode 5
•
26:12
GPO Legislative Townhall May 2023: Part 4
In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA.Our next e...
•
Episode 4
•
12:01
GPO Legislative Townhall Feb 2023: Part 3
In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations.Our next episode will feat...
•
Episode 3
•
22:58
GPO Legislative Townhall Feb 2023: Part 2
In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment.Our next episode will feature information on the In...
•
Episode 2
•
18:40
GPO Legislative Townhall Feb 2023: Part 1
In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disp...
•
13:59
Operational Pathways for Biomarker Testing in NSCLC
In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses consider...
•
12:03
Biosimilar Series: Part 5
In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for bi...
•
Episode 5
•
11:48
Biosimilar Series: Part 4
In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the difference...
•
Episode 4
•
8:51
Biosimilar Series: Part 3
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safet...
•
Episode 3
•
9:45
Biosimilar Series: Part 2
In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss the history of biosimilars, the reception o...
•
15:31
Biosimilar Series: Part 1
In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchan...
•
9:36
Biomarkers: Emerging Targets and Technologies
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of ...
•
11:46
Biomarker Testing: A Closer Look at When, Who, and How to Test
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and...
•
14:00